Clinical Trial Update: Study to Evaluate the Safety and Efficacy of Pradaxar for the Prevention of Venous Thromboembolism in the Mexican Population Undergoing Elective Total Hip or Knee Replacement Surgery

View source ↗

Summary

A terminated clinical trial evaluating Pradaxar (dabigatran) for prevention of venous thromboembolism in Mexican patients undergoing elective hip or knee replac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Deep Vein Thrombosis
• Pulmonary Embolism
• Venous Thromboembolism

Drugs mentioned

• Pradaxar (dabigatran)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Thromboembolism, Arthroplasty, Replacement, Hip | Status: TERMINATED | Results posted: 2012-04-05